News

SoloHealth names former Walgreens exec to BOD

November 15, 2011

The former president of Walgreens Health Services and senior vice president of the Walgreen Company, Stanley B. Blaylock, is now on the board of directors of SoloHealth, the company behind the consumer health screening kiosk, the SoloHealth Station.

Blaylock has more than 20 years of experience in the fields of health care, entrepreneurship and investment banking, according to a press release by SoloHealth.

"We are excited and honored that such a respected figure in the health care community has agreed to join the SoloHealth board, especially as we ready ourselves for what promises to be a fast-growing and pivotal next 12-18 months for the company," said Bart Foster, founder and CEO of SoloHealth. "Stan brings unparalleled finance, entrepreneurial and health care knowledge to SoloHealth and will provide invaluable counsel during this exciting time of growth as we roll out our new health care solution nationwide."

Blaylock began his career in health care investment banking, where he rose to the position of global co-head of health care investment banking at Deutsche Bank. In this capacity, he oversaw the execution of 149 financings for approximately $45 billion and 54 mergers and acquisitions of approximately $24 billion.

Blaylock went on to co-found specialty pharmacy solutions company Medmark, where he served as executive vice president/CFO and chief administrative officer until his promotion to president and CEO in 2005.

When Walgreens acquired Medmark in 2006, Blaylock joined the company, and through a series of quick promotions, became Walgreens senior vice president and president of Walgreens Health Services. During his four years at Walgreens, he successfully integrated Medmark, driving Walgreens Specialty Pharmacy to the No. 3 player in the industry through rapid internal growth and key strategic acquisitions. He was responsible for enhancing more than 7,100 community-based pharmacies and managed about 7,000 Walgreens employees with P&L responsibility for nearly $4 billion in revenues.

Blaylock currently serves on the Board of Directors of NovaSom Inc., a leading provider of home sleep-testing services for obstructive sleep apnea. He is also a member of the board of directors of MTS Medication Technologies, an international provider of adherence packaging systems, designed to improve medication dispensing and administration. He earned a degree in economics and communication studies from the University of Virginia and received his master's degree in business administration from the Harvard Business School. He is also a 2009 fellow of the CEO Perspective Program from Northwestern's Kellogg School of Management and Corporate Leadership Center.

Read more about kiosks in the health care industry.